Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
Helping the diabetes community in Ukraine
Please see this link to read the JDRF International statement on the ongoing crisis in Ukraine.
UPDATE: January 5, 2026 – Canada’s Drug Agency has just announced a decision not to reimburse Tzield (teplizumab) In Canada, reimbursement of therapeutics is based on recommendations from Canada’s Drug Agency (CDA) and Quebec’s Institut national d’excellence en santé et en services sociaux (INESSS). Applications for reimbursement review of Tzield (teplizumab) – the first disease-modifying […]
The following Op Ed was co-authored by Breakthrough T1D’s President and CEO, Jessica Diniz and Cate Murray, President and CEO of the Stem Cell Network and was published in the Hill Times on October 30. — From insulin to regenerative therapy, Canada’s contribution to diabetes research is unmatched. The question is whether we’ll continue to […]
CFKF will be proudly naming the Breakthrough T1D Canucks For Kids Fund Centre of Excellence at UBC. VANCOUVER, BC – October 30, 2025 – The Canucks For Kids Fund (CFKF) has made a transformational investment to Breakthrough T1D Canada to support the most promising type 1 diabetes (T1D) cure research, proudly naming the Breakthrough T1D […]
